Search
for
Sort by
Research 241–270 of 1000+
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Treatment of Alopecia Areata With Tofacitinib
- Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- THU0189 Safety of four treatment regimens in early rheumatoid arthritis
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Evaluation and treatment of male and female pattern hair loss
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Management of Hair Loss
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Androgens in women
- Tinea capitis in adult women masquerading as bacterial pyoderma
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Treatment of severe alopecia areata with baricitinib
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata